Use of Corticosteroids in a Population-Based Cohort of Boys With Duchenne and Becker Muscular Dystrophy
The DOI matches its Crossref record.
Abstract
The use of corticosteroids for treatment of Duchenne and Becker muscular dystrophy in clinical practice from 1991 through 2005 was reviewed in a large population-based cohort (MD STARnet) of boys in 4 regional sites and 6 clinics of the United States. Corticosteroid use increased from 20% (11 of 56 individuals) in 1991 to 44% (93 of 218 individuals) in 2005. Average use varied by site and ranged from 15% to 49%. The median age of corticosteroid initiation was 6.9 years (range, 3.7-17.4 years). Dosage and growth information was available for 102 participants and showed a median dose as 0.729 mg/kg for prednisone and 0.831 mg/kg for deflazacort. T. The most common reasons that corticosteroids were discontinued included weight gain, behavioral side effects, and loss of ambulation, resulting in full-time wheelchair use. Substantial variations in clinical practice were identified among study sites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Behavioural problems are one of the most common reasons to discontinue treatment (Poysky, 2007; Matthews et al., 2010).”
From Understanding Duchenne muscular dystrophy-associated brain pathology (2025) · cites this paper as Matthews et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 24
- 10.1016/0960-8966(91)90039-U · DOI · Paper page
- van Essen AJ, 2004, Online Leyden Muscular Dystrophy pages
- 10.1016/S0140-6736(74)90071-3 · DOI · Paper page
- 10.1002/mus.880111110 · DOI
- 10.1002/mus.880070704 · doi:10.1002/mus.880070704
- 10.1002/mus.880100106 · doi:10.1002/mus.880100106
- 10.1097/01.phm.0000184156.98671.d0 · DOI · Paper page
- 10.1542/pir.27-3-83 · doi:10.1542/pir.27-3-83
- 10.1067/mpd.2001.109601 · DOI · Paper page
- 10.1016/j.nmd.2006.01.010 · DOI · Paper page
- 10.1212/WNL.41.12.1874 · DOI · Paper page
- 10.1212/01.wnl.0000260974.41514.83 · DOI · Paper page
- 10.1001/archneur.1987.00520200016010 · DOI
- 10.1007/s11910-001-0013-y · DOI
- 10.1177/088307380201700306 · DOI
- 10.1136/jmg.34.10.805 · DOI
- 10.1111/j.1468-1331.2004.00866.x · DOI
- 10.1212/01.WNL.0000148485.00049.B7 · DOI · Paper page
- 10.1212/WNL.43.3_Part_1.520 · DOI · Paper page
- 10.1002/bdra.20279 · DOI
- SAS Institute, Inc., 2000, SAS 9.1.3 Help and Documentation
- 10.1136/adc.2007.118141 · doi:10.1136/adc.2007.118141
- Griggs RC, 1991, Clinical Investigation of Duchenne Dystrophy Group. Arch Neurol, 48, 383
- 10.1056/NEJM198906153202405 · DOI · Paper page
Cited by
Mcdonald, C. M., Henricson, E. K., Abresch, R. T., Florence, J. M., Eagle, M., Gappmaier, E., Glanzman, A. M., PTC124‐GD‐007‐DMD Study Group, Spiegel, R., Barth, J., et al. (2013) · Muscle & Nerve · doi:10.1002/mus.23902 · Cited by 303
Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids
Baehr, L. M., Furlow, J. D., & Bodine, S. C. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.212845 · Cited by 234
“Synthetic glucocorticoids are widely used to treat inflammation (Rhen & Cidlowski, 2005) and muscular dystrophy (Matthews et al. 2010); however, they induce serious side effects such as muscle and bone loss (Decramer et al. 1994; Barry & Gallagher, 2003) and insulin resistance (Stojanovska et al.…”
BackgroundUnderstanding Duchenne muscular dystrophy-associated brain pathology
Verhaeg, M. A. T., Govaarts, R., & van Putten, M. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.052302 · Cited by 5
Metadata
- Authors
- Matthews, D. J., James, K. A., Miller, L. A., Pandya, S., Campbell, K. A., Ciafaloni, E., Mathews, K. D., Miller, T. M., Cunniff, C., Meaney, F. J., Druschel, C. M., Romitti, P. A., Fox, D. J., & STARnet, M.
- Affiliations
- Department of Physical Medicine & Rehabilitation, University of Colorado School of Medicine and The Children's Hospital, Denver, CO, USA,
- Colorado Department of Public Health and Environment, Denver, CO, USA
- Department of Neurology, University of Rochester College of Medicine and Dentistry, Rochester, NY, USA
- New York Department of Health, Troy, NY, USA
- Department of Pediatrics, University of Iowa College of Medicine, Iowa City, IA, USA
- The Departments of Pediatrics and Neurology and the Steele Research Center, University of Arizona College of Medicine, Tucson, AZ, USA
- Department of Epidemiology, The University of Iowa College of Public Health, Iowa City, IA, USA
- Venue
- Journal of Child Neurology
- Publisher
- SAGE Publications
- Published
- 2010-03-05
- Volume
- 25
- Issue
- 11
- Pages
- 1319-1324
- ISSN
- 0883-0738
- 1708-8283
- Cited by
- 47
- References
- 0
- Language
- en
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Use of Corticosteroids in a Population-Based Cohort of Boys With Duchenne and Becker Muscular Dystrophy. https://app.cochat.ai/papers/10.1177/0883073810362762
- The paper
- Matthews, D. J., James, K. A., Miller, L. A., Pandya, S., Campbell, K. A., Ciafaloni, E., Mathews, K. D., Miller, T. M., Cunniff, C., Meaney, F. J., Druschel, C. M., Romitti, P. A., Fox, D. J., & STARnet, M. (2010). Use of Corticosteroids in a Population-Based Cohort of Boys With Duchenne and Becker Muscular Dystrophy. Journal of Child Neurology. https://doi.org/10.1177/0883073810362762
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.